CD19 and acute lymphoblastic leukemia: Additionally, several CAR constructs were engineered to recognize ALL and AML antigens such as CD19 (37, 70, 71), CD33 (71, 72), and CD123 (73, 74), incorporating a hinge region derived from CD34 to facilitate detection and selection of transduced NK cells.